+ − Summary
+ − Full Texts (2)
+ − Actions (27)
- Signed by Governor (Acts, ch. 119)
- Delivered to Governor
- Enrolled, signed by each presiding officer
- Passed 96-1
- House concurred in Senate Committee Substitute, committee amendment (1-title)
- Posted for passage for concurrence in Senate Committee Substitute, committee amendment (1-title)
- Taken from Rules
- To Rules (H)
- Received in House
- 3rd reading, passed 38-0 with Committee Substitute, committee amendment (1-title)
- Posted for passage in the Consent Orders of the Day for Wednesday, March 26, 2014
- Reported favorably, to Rules with Committee Substitute, committee amendment (1-title) as a Consent Bill
- Taken from Banking & Insurance (S)
- 2nd reading
- Returned to Banking & Insurance (S)
- Returned to Banking & Insurance (S)
- 1st reading
- Taken from Banking & Insurance (S)
- To Banking & Insurance (S)
- Received in Senate
- 3rd reading, passed 96-0 with Committee Substitute
- Posted for passage in the Consent Orders of the Day for Wednesday, January 22, 2014
- 2nd reading, to Rules
- Reported favorably, 1st reading, to Consent Calendar with Committee Substitute
- Posted in committee
- To Banking & Insurance (H)
- Introduced in House
+ − Amendments (3)
SCS
Retain original provisions, except create a new section of Subtitle 17A of KRS Chapter 304 to define "anticancer medications"; require that health benefit plans not require a higher copayment, coinsurance, or deductible for patient administered anticancer medications than are required for anti-cancer medications injected or intravenously administered by a health care provider, prohibit specified actions to circumvent this provision; add a subsection to provide that subsection (4) of this section does not apply to a health benefit plan that meets the federal definition of a high deductible health plan to be used in conjunction with a health savings account until the insured's deductible has been satisfied.
SCA (1/Title, T. Buford)
Make title amendment.
HCS
Make technical corrrections.